Increased GATA-3 and T-bet expression in eosinophilic esophagitis versus gastroesophageal reflux disease

Benjamin L. Wright; Nathalie Nguyen; Kelly P. Shim; Joanne C. Masterson; Elizabeth A. Jacobsen; Sergei I. Ochkur; James J. Lee; Glenn T. Furuta

doi:10.1016/j.jaci.2017.12.993

Increased GATA-3 and T-bet expression in eosinophilic esophagitis versus gastroesophageal reflux disease

Benjamin L. Wright, Nathalie Nguyen, Kelly P. Shim, Joanne C. Masterson, Elizabeth A. Jacobsen, Sergei I. Ochkur, James J. Lee, Glenn T. Furuta

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1919-1921.e5
Journal	Journal of Allergy and Clinical Immunology
Volume	141
Issue number	5
DOIs	https://doi.org/10.1016/j.jaci.2017.12.993
State	Published - May 2018

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2017.12.993

Cite this

@article{d564927d7ae141d096241daf7c6b3392,

title = "Increased GATA-3 and T-bet expression in eosinophilic esophagitis versus gastroesophageal reflux disease",

author = "Wright, {Benjamin L.} and Nathalie Nguyen and Shim, {Kelly P.} and Masterson, {Joanne C.} and Jacobsen, {Elizabeth A.} and Ochkur, {Sergei I.} and Lee, {James J.} and Furuta, {Glenn T.}",

note = "Funding Information: Disclosure of potential conflict of interest: B. L. Wright's institution received a grant from Don and Kathy Levin Family Foundation for this work. E. A. Jacobsen's institution received a grant from the National Institutes of Health (NIH) for this work. G. T. Furuta received consultancy fees from Shire; grants from the Food and Drug Administration and the NIH for other works; and royalties from UpToDate. J. J. Lee is cofounder of EnteroTrack. Funding Information: This study was funded by Mayo Clinic, Phoenix Children's Hospital Foundation, and Don and Kathy Levin Family Foundation (B.L.W., J.J.L.). This work was also supported by the Consortium of Eosinophilic Gastrointestinal Disease Researchers (grant no. U54AI117804), which is part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Disease Research, National Center for Advancing Translational Sciences (NCATS), and is funded through a collaboration between the National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, NCATS, and patient advocacy groups including the American Partnership for Eosinophilic Disorders (APFED), the Campaign Urging Research for Eosinophilic Disease (CURED) and the Eosinophilic Family Coalition (EFC). The National Institutes of Health provided grants 1K24DK100303 (G.T.F.) and T32DK067009-11 (N.N.). This work benefitted from data assembled by the ImmGen consortium. ",

year = "2018",

month = may,

doi = "10.1016/j.jaci.2017.12.993",

language = "English (US)",

volume = "141",

pages = "1919--1921.e5",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Increased GATA-3 and T-bet expression in eosinophilic esophagitis versus gastroesophageal reflux disease

AU - Wright, Benjamin L.

AU - Nguyen, Nathalie

AU - Shim, Kelly P.

AU - Masterson, Joanne C.

AU - Jacobsen, Elizabeth A.

AU - Ochkur, Sergei I.

AU - Lee, James J.

AU - Furuta, Glenn T.

N1 - Funding Information: Disclosure of potential conflict of interest: B. L. Wright's institution received a grant from Don and Kathy Levin Family Foundation for this work. E. A. Jacobsen's institution received a grant from the National Institutes of Health (NIH) for this work. G. T. Furuta received consultancy fees from Shire; grants from the Food and Drug Administration and the NIH for other works; and royalties from UpToDate. J. J. Lee is cofounder of EnteroTrack. Funding Information: This study was funded by Mayo Clinic, Phoenix Children's Hospital Foundation, and Don and Kathy Levin Family Foundation (B.L.W., J.J.L.). This work was also supported by the Consortium of Eosinophilic Gastrointestinal Disease Researchers (grant no. U54AI117804), which is part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Disease Research, National Center for Advancing Translational Sciences (NCATS), and is funded through a collaboration between the National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, NCATS, and patient advocacy groups including the American Partnership for Eosinophilic Disorders (APFED), the Campaign Urging Research for Eosinophilic Disease (CURED) and the Eosinophilic Family Coalition (EFC). The National Institutes of Health provided grants 1K24DK100303 (G.T.F.) and T32DK067009-11 (N.N.). This work benefitted from data assembled by the ImmGen consortium.

PY - 2018/5

Y1 - 2018/5

UR - http://www.scopus.com/inward/record.url?scp=85042216279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042216279&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2017.12.993

DO - 10.1016/j.jaci.2017.12.993

M3 - Article

C2 - 29374572

AN - SCOPUS:85042216279

SN - 0091-6749

VL - 141

SP - 1919-1921.e5

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 5

ER -

Increased GATA-3 and T-bet expression in eosinophilic esophagitis versus gastroesophageal reflux disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this